Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mairs & Power Growth Fund Investor Class (MPGFX)

Net Asset Value
1 Day
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to provide shareholders with a diversified portfolio of common stocks, which have the potential for above-average, long-term appreciation. The fund invests primarily in U.S. common stocks. It may also invest in securities of foreign issuers which are listed on a U.S. stock exchange or are represented by American Depositary Receipts. In selecting securities for the fund, its investment adviser gives preference to holdings in high quality companies, which are characterized by earnings that are reasonably predictable, have a return on equity that is above-average, hold market dominance and have financial strength.


1 month-1.22% 3 years+8.25%
3 months+0.66% 5 years+13.33%
1 year+8.62% Since inception+11.34%
Data through --

Peer Comparisonvs. Large blend

Performance 5-yr return+13.33%+13.35%
Expense ratio0.66%1.00%
Risk 5 year sharpe ratio1.311.31
Net assets$4.6B$4.9B
Average market cap$31.0B$113.2B
Average P/E23.321.8
Portfolio turnover11%11%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMairs & Power
Fund manager & tenureMark Henneman / 11 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00


U.S. stock95.44%
International stock2.89%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 41.65%
Healthcare 18.38%
Financial service 12.97%
Business service 8.08%
Consumer goods 6.82%
Top 10 Holdings
Portfolio weighting
ECL Ecolab Inc4.94%
USB U.S. Bancorp4.60%
MMM 3M4.17%
GGG Graco Inc4.16%
MDT Medtronic PLC4.00%
HON Honeywell3.95%
JNJ Johnson & Johnson3.74%
DCI Donaldson Company Inc3.35%
HRL Hormel Foods Corp3.12%
ABT Abbott Laboratories3.02%